東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Antidepressants = from biogenic amin...

Macaluso, Matthew.

Linked to FindBook

Google Book

Amazon

博客來

Antidepressants = from biogenic amine to new mechanisms of action /

Record Type:	Electronic resources : Monograph/item
Title/Author:	Antidepressants/ edited by Matthew Macaluso, Sheldon H. Preskorn.
Reminder of title:	from biogenic amine to new mechanisms of action /
other author:	Macaluso, Matthew.
Published:	Cham :Springer International Publishing : : 2019.,
Description:	xii, 442 p. :ill., digital ;24 cm.
[NT 15003449]:	Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past - from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.
Contained By:	Springer eBooks
Subject:	Antidepressants. -
Online resource:	https://doi.org/10.1007/978-3-030-10949-3
ISBN:	9783030109493

Antidepressants = from biogenic amine to new mechanisms of action /
Antidepressantsfrom biogenic amine to new mechanisms of action /[electronic resource] :edited by Matthew Macaluso, Sheldon H. Preskorn. - Cham :Springer International Publishing :2019. - xii, 442 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2500171-2004 ;. - Handbook of experimental pharmacology ;v.250..

Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past - from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.

This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.

ISBN: 9783030109493

Standard No.: 10.1007/978-3-030-10949-3doiSubjects--Topical Terms:

922074
Antidepressants.

LC Class. No.: RM332 / .A58 2019

Dewey Class. No.: 615.78

Antidepressants = from biogenic amine to new mechanisms of action /
LDR:02523nmm a2200337 a 4500 001 2191108
003 DE-He213
005 20191016165502.0
006 m d
007 cr nn 008maaau
008 200504s2019 gw s 0 eng d
020 $a 9783030109493 $q (electronic bk.)
020 $a 9783030109486 $q (paper)
024 7 $a 10.1007/978-3-030-10949-3 $2 doi
035 $a 978-3-030-10949-3
040 $a GP $c GP
041 0 $a eng
050 4 $a RM332 $b .A58 2019
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 615.78 $2 23
090 $a RM332 $b .A629 2019
245 0 0 $a Antidepressants $h [electronic resource] : $b from biogenic amine to new mechanisms of action / $c edited by Matthew Macaluso, Sheldon H. Preskorn.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xii, 442 p. : $b ill., digital ; $c 24 cm.
490 1 $a Handbook of experimental pharmacology, $x 0171-2004 ; $v v.250
505 0 $a Part 1: Overview and General Principles -- 1. Impact, Diagnosis, Phenomenology, and Biology -- Part 2: The Past - from antiquity to 1970 including TCAs and MAOIs -- 2. Tricyclic Antidepressants and Monoamine Oxidase Inhibitors: Are They Too Old for a New Look? -- Part 3: The Present- 1970 to 2016 -- 3. Clinical Implications of the STAR*D Trial -- 4. Pharmacogenomics and Biomarkers of Depression -- 5. Therapeutic Drug Monitoring of Antidepressants -- 6. Selective Serotonin Reuptake Inhibitors -- 7. Serotonin and Norepinephrine Reuptake Inhibitors -- 8. Neurostimulation Therapies -- 9. Current Role of Herbal and Natural Preparations -- Part 4: The future -- 10. Role of Inflammation in Depression and Treatment Implications -- 11. NMDA Antagonists for Treatment-Resistant Depression -- 12. Drug Development in Psychiatry: The Long and Winding Road from Chance Discovery to Rational Development -- 13. Other Antidepressants -- Part 5: Use of Antidepressants in Special Populations -- 14. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders -- 15. Treatment of Depression in Women -- 16. Management of Late-Life Depression -- 17. The Use of Antidepressants in Bipolar Depression.
520 $a This volume reviews the known neurobiology of depression and combines classic data on antidepressant treatments with modern theory on the physiology of depression. It also discusses novel mechanism of action drugs.
650 0 $a Antidepressants. $3 922074
650 1 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Psychopharmacology. $3 568143
650 2 4 $a Neurosciences. $3 588700
700 1 $a Macaluso, Matthew. $3 3410185
700 1 $a Preskorn, Sheldon H. $3 3410186
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Handbook of experimental pharmacology ; $v v.250. $3 3410187
856 4 0 $u https://doi.org/10.1007/978-3-030-10949-3
950 $a Biomedical and Life Sciences (Springer-11642)